None listed
Conditions
Brief summary
This study builds on and extends a previous project that tested a group intervention for cancer survivors who have experienced problems with cognitive functions such as attention and memory. The study uses a more rigorous research design (random allocation to treatment or waitlist) and also tests potential reasons that the treatment may be effective. It was hypothesised that participants in the treatment group would show bigger improvements in objective cognitive function, subjective cognitive function and other self-report measures than participants on a waitlist or healthy control participants. It was also predicted that better cognitive function would be associated with higher self-efficacy and more favourable illness perceptions
Interventions
"ReCog" is a four-week manualised intervention based on principles of cognitive behavioural therapy and cognitive rehabilitation. It comprises 4 two-hour sessions involving education, skills training and skills practice on topics such as memory and attention, and between-session homework. The intervention is delivered in weekly group sessions of 3-10 participants with 2 facilitators. Homework takes approximately 30-60 minutes per week. Treatment adherence is monitored via session attendance and
"ReCog" is a four-week manualised intervention based on principles of cognitive behavioural therapy and cognitive rehabilitation. It comprises 4 two-hour sessions involving education, skills training and skills practice on topics such as memory and attention, and between-session homework. The intervention is delivered in weekly group sessions of 3-10 participants with 2 facilitators. Homework takes approximately 30-60 minutes per week. Treatment adherence is monitored via session attendance and homework completion
Sponsors
Griffith University
Study design
Allocation
Randomised controlled trial
Intervention model
Other
Primary purpose
Educational / counselling / training
Masking
Blinded (masking used) (Outcomes Assessor)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
18 years or more; experienced adult-onset cancer (excluding cancer known to have affected the central nervous system); completed all major treatments for cancer (such as surgery, chemotherapy, and radiotherapy) at least 6 months prior to data collection (but ongoing hormone treatments were acceptable, e.g. oestrogen modifiers or androgen-suppressing medications); subjective cognitive impairment as shown by a score of <100 on the EORTC-QLQ-C30 cognitive function subscale. Healthy volunteers were required to be 18 years or over and have never been diagnosed with cancer.
Exclusion criteria
Cancer known to involve the central nervous system (primary or secondary tumours). Previous treatment with cranial radiotherapy or intrathecal chemotherapy.
Outcome results
None listed